SCHEMBL4033240

SCHEMBL4033240

COc1cc2c(cc1OCCN1CCOCC1)ncn2-c1cc(OCc2ccccc2C(F)(F)F)c(C#N)s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKE Q14164 11/20 1.00
PLK1 P53350 11/20 0.78
PLK4 O00444 2/20 0.57
AURKA O14965 2/20 0.57
JAK2 O60674 2/20 0.57
LCK P06239 2/20 0.57
CSF1R P07333 2/20 0.57
FGFR1 P11362 2/20 0.57
SRC P12931 2/20 0.57
FLT1 P17948 2/20 0.57
CDK2 P24941 2/20 0.57
AXL P30530 2/20 0.57
FLT4 P35916 2/20 0.57
KDR P35968 2/20 0.57
GSK3B P49841 2/20 0.57
NEK2 P51955 2/20 0.57
JAK3 P52333 2/20 0.57
LIMK1 P53667 2/20 0.57
STK3 Q13188 2/20 0.57
DYRK1A Q13627 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14490097 0.92 IKBKE (0.85) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4038453 0.88 IKBKE (1.00) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4035225 0.87 IKBKE (1.00) IKBKEPLK1SRCTBK1
SCHEMBL5067369 0.86 PLK1 (0.78) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4041060 0.86 PLK1 (0.78) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4034641 0.86 IKBKE (1.00) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4210906 0.85 IKBKE (0.74) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL4037682 0.80 IKBKE (0.66) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL5410566 0.79 IKBKE (0.66) IKBKEPLK1PLK4AURKAJAK2
SCHEMBL5058163 0.79 PLK1 (0.81) IKBKEPLK1PLK4AURKAJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720864-B1 BENZIMIDAZOL SUBSTITUTED THIOPHENE DERIVATIVES WITH ACTIVITY ON IKK3 GLAXO GROUP LTD (GB) 2009-05-06 EP claimed
EP-2259787-B1 IKKI INHIBITOR THERAPIES AND SCREENING METHODS, AND RELATED IKKI DIAGNOSTICS UNIV MICHIGAN (US) 2015-12-23 EP disclosed